Comparative Effectiveness of 10% Urea Cream and 0.1% Hyaluronic Acid Cream in Diabetic Xerosis: A Prospective Split-Body Clinical Trial
Abstract
Objective: Xerosis cutis is a common dermatological complication in diabetes mellitus and is associated with impaired skin barrier function. This study compared the efficacy of 10% urea cream and 0.1% hyaluronic acid cream in improving skin hydration, reducing transepidermal water loss (TEWL), and alleviating xerosis severity in diabetic patients.
Material and Methods: A prospective split-body clinical trial was conducted in 30 adults with diabetic xerosis. Participants applied 10% urea cream to one lower leg and 0.1% hyaluronic acid cream to the contralateral leg twice daily for 28 days. Skin hydration, TEWL, and xerosis severity were evaluated using Corneometer® CM 825, Tewameter® TM Hex, and the Overall Dry Skin Score, respectively, at baseline, day 14±1, and day 28±1. Statistical analyses were performed using paired tests with a significance set at p-value<0.05.
Results: At day 28, the increase in skin hydration was significantly greater with urea cream than with hyaluronic acid cream (mean difference: 2.71 arbitrary units; 95% confidence interval: 0.56–4.86; p-value=0.015), corresponding to a moderate effect size (Cohen’s dz ≈ 0.47), suggesting a clinically meaningful difference.
Conclusion: In patients with diabetic xerosis, ten percent urea cream provided superior enhancement of skin hydration relative to 0.1% hyaluronic acid cream, whereas both formulations showed similar efficacy in improving barrier function and reducing clinical xerosis severity.
Keywords
Full Text:
PDF (Early Version)References
Demirseren DD, Emre S, Akoglu G, Arpacı D, Arman A, Metin A, et al. Relationship between skin diseases and extracutaneous complications of diabetes mellitus: Clinical analysis of 750 patients. Am J Clin Dermatol 2014;15:65–70. doi: 10.1007/s40257-013-0048-2.
Ha NG, Kim SL, Lee SH, Lee WJ. A novel hydrogel-based moisturizing cream composed of hyaluronic acid for patients with xerosis: an intraindividual comparative analysis. Skin Res Technol 2023;29:e13499. doi: 10.1111/srt.13499.
Lodén M. Treatments improving skin barrier function. In: Agner T, editor. Skin Barrier Function. Curr Probl Dermatol. Basel: Karger; 2016; p.112–22. doi: 10.1159/000441586.
Macedo GMC, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr 2016;8:63. doi: 10.1186/s13098-016-0176-y.
Stingeni L, Tramontana M, Cordera L, Castello M, Parodi A. Xerosis in patients with type 2 diabetes: An Italian multicentre study. Acta Derm Venereol 2021;101:adv00263. doi: 10.2340/actadv.v101.263.
Zhang S, Ke Z, Yang C, Zhou P, Jiang H, Chen L, et al. High glucose causes distinct expression patterns of primary human skin cells by RNA sequencing. Front Endocrinol (Lausanne) 2021;12:603645. doi: 10.3389/fendo.2021.603645.
Grether-Beck S, Felsner I, Brenden H, Kohne Z, Majora M, Marini A, et al. Urea uptake enhances barrier function and antimicrobial defense in human skin. J Invest Dermatol 2012;132:1561–72.
Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol 2012;4:253–8.
Park JH, Choi Y, Jung YJ, Lee T, Kim H, Cho Y, et al. Skin hydration measurement: comparison between devices and clinical evaluations. Ann Dermatol 2024;36:275-83. doi: 10.5021/ad.23.103.
Crowther et al. (please add 6 authors, et al.) What defines dry skin? Correlating electrical measures with visual grading. Int J Cosmet Sci 2024;Vol?:Pages?.
Sullivan GM, Feinn R. Using effect size—or why the p-value is not enough. J Grad Med Educ 2012;4:279–82.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.